• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Recent Advances in the Application of Methyl 5-Methoxypyrimidine-4-carboxylate (CAS: 64224-66-4) in Chemical Biology and Pharmaceutical Research

Methyl 5-methoxypyrimidine-4-carboxylate (CAS: 64224-66-4) has emerged as a key intermediate in the synthesis of bioactive compounds, particularly in the development of novel pharmaceuticals and agrochemicals. Recent studies have highlighted its versatility as a building block for pyrimidine-based scaffolds, which are widely utilized in drug discovery due to their structural diversity and pharmacological relevance. This research briefing provides an overview of the latest advancements involving this compound, focusing on its synthetic applications, biological activities, and potential therapeutic implications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the utility of methyl 5-methoxypyrimidine-4-carboxylate as a precursor for the synthesis of kinase inhibitors targeting cancer-related pathways. The compound's methoxy and carboxylate functional groups were strategically modified to enhance binding affinity to ATP pockets of target kinases, resulting in derivatives with nanomolar inhibitory activity. Structural-activity relationship (SAR) analyses revealed that substitutions at the 4-position significantly influenced selectivity profiles across kinase families.

Parallel developments in antimicrobial research have explored the compound's potential as a scaffold for novel antibacterial agents. A recent patent application (WO2023056424) disclosed pyrimidine derivatives synthesized from 64224-66-4 that exhibited potent activity against multidrug-resistant Gram-positive pathogens, with MIC values ranging from 0.5-4 μg/mL. Molecular docking studies suggested these compounds interfere with bacterial cell wall biosynthesis through novel mechanisms distinct from existing antibiotic classes.

The compound's role in agrochemical innovation has also gained attention. Research from the Pesticide Biochemistry and Physiology journal (2024) reported novel insecticidal compounds derived from methyl 5-methoxypyrimidine-4-carboxylate that showed selective toxicity against lepidopteran pests while maintaining favorable environmental safety profiles. These findings position 64224-66-4 as a valuable starting material for developing next-generation crop protection agents with reduced ecological impact.

From a synthetic chemistry perspective, recent methodological advances have improved the efficiency of transformations involving this pyrimidine derivative. A 2024 Organic Process Research & Development publication described a continuous-flow protocol that increased the yield of key intermediates by 35% while reducing solvent consumption compared to traditional batch processes. Such process intensification approaches are critical for scaling up production of derivatives for preclinical evaluation.

Emerging analytical techniques have further elucidated the compound's physicochemical properties. Quantum mechanical calculations published in Computational and Theoretical Chemistry (2023) provided detailed insights into the conformational preferences and electronic structure of methyl 5-methoxypyrimidine-4-carboxylate, enabling more rational design of derivatives. These computational studies were validated by X-ray crystallographic data showing characteristic hydrogen-bonding patterns that influence molecular packing and solubility.

Looking forward, the expanding applications of 64224-66-4 underscore its importance as a multifunctional building block in medicinal chemistry. Current research directions include exploring its incorporation into PROTACs (proteolysis targeting chimeras) and other targeted protein degradation platforms, as well as investigating its potential in radiopharmaceutical development through isotope labeling strategies. The compound's synthetic accessibility and structural modifiability continue to make it a valuable asset in drug discovery pipelines across multiple therapeutic areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)